Emicizumab PUPs and Nuwiq ITI Study
Public ClinicalTrials.gov record NCT04030052. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT04030052
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Emory University
- Other
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- HEMLIBRA Drug
- Nuwiq (Atlanta protocol) Drug
- Nuwiq (low dose protocol) Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 16, 2022
- Primary completion
- Jan 18, 2023
- Completion
- Jan 18, 2023
- Last update posted
- Jan 4, 2024
2022 – 2023
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Emory University/Children's Healthcare of Atlanta | Atlanta | Georgia | 30322 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Mindy_L_Simpson@rush.edu | Indianapolis | Indiana | 46260 | — |
| Children's Hospital of Michigan/ Wayne State University | Detroit | Michigan | 48201 | — |
| Weill Cornell Medicine | New York | New York | 10021 | — |
| University of North Carolina - Hemophilia and Thrombosis Center | Chapel Hill | North Carolina | 27599 | — |
| Verisiti, WI | Milwaukee | Wisconsin | 53233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04030052, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04030052 live on ClinicalTrials.gov.